Degradation of cyclin A is regulated by acetylation

Oncogene

Volumn 28, Issue 29, 2009, Pages 2654-2666

  Mateo, F ^a   Vidal Laliena, M ^a   Canela, N ^a   Busino, L ^b   Martinez Balbas, M A ^c   Pagano, M ^b   Agell, N ^a   Bachs, O ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c INSTITUT DE BIOLOGIA MOLECULAR DE BARCELONA   (Spain)

Author keywords

Acetylation; Cyclin A; Degradation; P CAF; Ubiquitylation

Indexed keywords

ANAPHASE PROMOTING COMPLEX; CELL CYCLE PROTEIN 20; CYCLIN A; CYCLIN DEPENDENT KINASE; HISTONE ACETYLTRANSFERASE PCAF; HISTONE DEACETYLASE INHIBITOR; LYSINE; UVOMORULIN;

ACETYLATION; AMINO TERMINAL SEQUENCE; ARTICLE; CELL CYCLE ARREST; CONTROLLED STUDY; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; MITOSIS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN INTERACTION; REGULATORY MECHANISM; UBIQUITINATION;

ACETYLATION; ANIMALS; CERCOPITHECUS AETHIOPS; COS CELLS; CYCLIN A; CYCLIN-DEPENDENT KINASE 2; HELA CELLS; HUMANS; LYSINE; MUTATION; P300-CBP TRANSCRIPTION FACTORS;

EID: 68049118558     PISSN: 09509232     EISSN: 14765594     Source Type: Journal    
DOI: 10.1038/onc.2009.127     Document Type: Article

References (42)

1. Abramova MV, Pospelova TV, Nikulenkov FP, Hollander CM, Fornace Jr AJ, Pospelov VA. (2006). G1/S arrest induced by histone deacetylase inhibitor sodium butyrate in E1A + Ras-transformed cells is mediated through down-regulation of E2F activity and stabilization of beta-catenin. J Biol Chem 281: 21040-21051.
2. Baek SY, Kim SR, Bae MK, Hwang JW, Kim JS, Choi YH et al. (2006). Trichostatin A increases the thermosensitivity of human glioblastoma A172 cells. Neurosci Lett 396: 230-234.
3. Bloom J, Cross FR. (2007). Multiple levels of cyclin specificity in cell-cycle control. Nat Rev Mol Cell Biol 8: 149-160. (Pubitemid 46432532)
4. Canela N, Orzaez M, Fucho R, Mateo F, Gutierrez R, Pineda-Lucena A et al. (2006). Identification of an hexapeptide that binds to a surface pocket in cyclin A and inhibits the catalytic activity of the complex cyclin-dependent kinase 2-cyclin A. J Biol Chem 281: 35942-35953. (Pubitemid 46041326)
5. den Elzen N, Pines J. (2001). Cyclin A is destroyed in prometaphase and can delay chromosome alignment and anaphase. J Cell Biol 153: 121-136.
6. Donzelli M, Squatrito M, GanothD, Hershko A, Pagano M, Draetta GF. (2002). Dual mode of degradation of Cdc25 A phosphatase. EMBO J 21: 4875-4884.
7. Fang G, Yu H, Kirschner MW. (1998). Direct binding of CDC20 protein family members activates the anaphase-promoting complex in mitosis and G1. Mol Cell 2: 163-171. (Pubitemid 128373642)
8. Fung TK, Yam CH, Poon RY. (2005). The N-terminal regulatory domain of cyclin A contains redundant ubiquitination targeting sequences and acceptor sites. Cell Cycle 4: 1411-1420.
9. Furuno N, den Elzen N, Pines J. (1999). Human cyclin A is required for mitosis until mid prophase. J Cell Biol 147: 295-306. (Pubitemid 29496339)
10. Galbiati L, Mendoza-Maldonado R, Gutierrez MI, Giacca M. (2005). Regulation of E2F-1 after DNA damage by p300-mediated acetylation and ubiquitination. Cell Cycle 4: 930-939. (Pubitemid 41359760)
11. Geley S, Kramer E, Gieffers C, Gannon J, Peters JM, Hunt T. (2001). Anaphase-promoting complex/cyclosome-dependent proteolysis of human cyclin A starts at the beginning of mitosis and is not subject to the spindle assembly checkpoint. J Cell Biol 153: 137-148. (Pubitemid 34280200)
12. Glotzer M, Murray AW, Kirschner MW. (1991). Cyclin is degraded by the ubiquitin pathway. Nature 349: 132-138.
13. Gong D, Pomerening JR, Myers JW, Gustavsson C, Jones JT, Hahn AT et al. (2007). Cyclin A2 regulates nuclear-envelope breakdown and the nuclear accumulation of cyclin B1. Curr Biol 17: 85-91. (Pubitemid 46039878)
14. Gu W, Roeder RG. (1997). Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain. Cell 90: 595-606. (Pubitemid 27357952)
15. Hagting A, den Elzen N, Vodermaier HC, Waizenegger IC, Peters JM, Pines J. (2002). Human securin proteolysis is controlled by the spindle checkpoint and reveals when the APC/C switches from activation by Cdc20 to Cdh1. J Cell Biol 157: 1125-1137. (Pubitemid 34847784)
16. Hecht A, Laroche T, Strahl-Bolsinger S, Gasser SM, Grunstein M. (1995). Histone H3 and H4 N-termini interact with SIR3 and SIR4 proteins: a molecular model for the formation of heterochromatin in yeast. Cell 80: 583-592.
17. Imhof A, Yang XJ, Ogryzko VV, Nakatani Y, Wolffe AP, Ge H. (1997). Acetylation of general transcription factors by histone acetyltransferases. Curr Biol 7: 689-692. (Pubitemid 27408867)
18. Jeong JW, Bae MK, Ahn MY, Kim SH, Sohn TK, Bae MH et al. (2002). Regulation and destabilization of HIF-1alpha by ARD1- mediated acetylation. Cell 111: 709-720.
19. Klotzbucher A, Stewart E, Harrison D, Hunt T. (1996). The 'destruction box' of cyclin A allows B-type cyclins to be ubiquitinated, but not efficiently destroyed. EMBO J 15: 3053-3064.
20. Leduc C, Claverie P, Eymin B, Col E, Khochbin S, Brambilla E et al. (2006). p14ARF promotes RB accumulation through inhibition of its Tip60-dependent acetylation. Oncogene 25: 4147-4154. (Pubitemid 44079448)
21. Li M, Luo J, Brooks CL, Gu W. (2002). Acetylation of p53 inhibits its ubiquitination by Mdm2. J Biol Chem 277: 50607-50611. (Pubitemid 36042220)
22. Linares LK, Kiernan R, Triboulet R, Chable-Bessia C, Latreille D, Cuvier O et al. (2007). Intrinsic ubiquitination activity of PCAF controls the stability of the oncoprotein Hdm2. Nat Cell Biol 9: 331-338. (Pubitemid 46344613)
23. Malumbres M, Barbacid M. (2005). Mammalian cyclin-dependent kinases. Trends Biochem Sci 30: 630-641.
24. Martinez-Balbas MA, Bauer UM, Nielsen SJ, Brehm A, Kouzarides T. (2000). Regulation of E2F1 activity by acetylation. EMBO J 19: 662-671.
25. Morgan DO. (1997). Cyclin-dependent kinases: engines, clocks, and microprocessors. Annu Rev Cell Dev Biol 13: 261-291.
26. Nagy Z, Tora L. (2007). Distinct GCN5/PCAF-containing complexes function as co-activators and are involved in transcription factor and global histone acetylation. Oncogene 26: 5341-5357. (Pubitemid 47255920)
27. Nilsson J, Yekezare M, Minshull J, Pines J. (2008). The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction. Nat Cell Biol 10: 1411-1420.
28. Pagano M, Draetta G. (1991). Cyclin A, cell cycle control and oncogenesis. Prog Growth Factor Res 3: 267-277. (Pubitemid 121007609)
29. Parry DH, O'Farrell PH. (2001). The schedule of destruction of three mitotic cyclins can dictate the timing of events during exit from mitosis. Curr Biol 11: 671-683.
30. Patel JH, Du Y, Ard PG, Phillips C, Carella B, Chen CJ et al. (2004). The c-MYC oncoprotein is a substrate of the acetyltransferases hGCN5/PCAF and TIP60. Mol Cell Biol 24: 10826-10834. (Pubitemid 39603138)
31. Ramachandran V, Matzkies M, Dienemann A, Sprenger F. (2007). Cyclin A degradation employs preferentially used lysines and a cyclin box function other than Cdk1 binding. Cell Cycle 6: 171-181. (Pubitemid 46232498)
32. Resnitzky D, Hengst L, Reed SI. (1995). Cyclin A-associated kinase activity is rate limiting for entrance into S phase and is negatively regulated in G1 by p27Kip1. Mol Cell Biol 15: 4347-4352.
33. Rosenberg AR, Zindy F, Le Deist F, Mouly H, Metezeau P, Brechot C et al. (1995). Overexpression of human cyclin A advances entry into S phase. Oncogene 10: 1501-1509.
34. Sadoul K, Boyault C, Pabion M, Khochbin S. (2008). Regulation of protein turnover by acetyltransferases and deacetylases. Biochimie 90: 306-312. (Pubitemid 351172566)
35. Sakaguchi K, Herrera JE, Saito S, Miki T, Bustin M, Vassilev A et al. (1998). DNA damage activates p53 through a phosphorylation-acetylation cascade. Genes Dev 12: 2831-2841. (Pubitemid 28440142)
36. Schiltz RL, Nakatani Y. (2000). The PCAF acetylase complex as a potential tumor suppressor. Biochim Biophys Acta 1470: M37-M53.
37. Sherr CJ, Roberts JM. (1999). CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev 13: 1501-1512.
38. Shimazu T, Komatsu Y, Nakayama KI, Fukazawa H, Horinouchi S, Yoshida M. (2006). Regulation of SV40 large T-antigen stability by reversible acetylation. Oncogene 25: 7391-7400. (Pubitemid 44853430)
39. Sudakin V, Chan GK, Yen TJ. (2001). Checkpoint inhibition of the APC/C in HeLa cells is mediated by a complex of BUBR1, BUB3, CDC20, and MAD2. J Cell Biol 154: 925-936. (Pubitemid 34286173)
40. Sullivan M, Morgan DO. (2007). Finishing mitosis, one step at a time. Nat Rev Mol Cell Biol 8: 894-903. (Pubitemid 47622563)
41. van Leuken R, Clijsters L, Wolthuis R. (2008). To cell cycle, swing the APC/C. Biochim Biophys Acta 1786: 49-59.
42. Wolthuis R, Clay-Farrace L, van Zon W, Yekezare M, Koop L, Ogink J et al. (2008). Cdc20 and Cks direct the spindle checkpoint-independent destruction of cyclin A. Mol Cell 30: 290-302. (Pubitemid 351615313)